Newborn Screening - Global Market Outlook (2015-2022)

Newborn Screening - Global Market Outlook (2015-2022)

  • Published: May 2016
  • ID: SMRC15684

According to Stratistics MRC, the newborn screening market is estimated at $540.4 million in 2015 and is projected to reach $1,240.2 million by 2022 growing at a CAGR of 12.6% from 2015 to 2022. Rising awareness and demand for newborn screening in developed nations, presence of federal bodies for organizing awareness programmes, rising paranoia of parents and government initiatives are some of the key factors driving the market growth. Additionally, technological advancements, increasing benefits related to newborn screening and growing array of new born diseases are some of the factors contemplated to fuel the market growth. However, lack of skilled professionals and lack of awareness in developing regions are the major restraints inhibiting the market growth. Furthermore, Next-Generation Sequencing (NGS) is anticipated to provide growth opportunities for the newborn screening market.

Dry blood spot test segment is expected to witness highest growth on account of rapidly launching new and advanced products. Due to cost effectiveness and time effectiveness provided by mass spectrometry, tandem mass spectroscopy market dominated the global newborn screening technology market. North America accounted for the largest share in newborn screening market followed by Europe. Rapid technological advancements due to considerable R & D activities, enhanced insurance coverage and stable healthcare infrastructure are the major factors favouring the North American market over the forecast period. However, Asia Pacific is expected to witness highest growth on account of rapidly expanding healthcare industry and rising awareness.

Some of the key players in this market include GE Healthcare, Covidien, Plc., Agilent Technologies Inc., Masimo Corp., Perkinelmer, Inc., AB Sciex LLC, Natus Medical Inc, Waters Corporation, Trivitron Healthcare , Bio-Rad Laboratories, Inc., Quest Diagnostics Inc, Illumina, Inc. and Laboratory Corporation of America Holdings.

Test Types Covered:
• Critical Congenital Heart Disease (CCHD)
• Dry Blood Spot Test
• Hearing Screen

Product Covered:
• Reagents and Assay Kits
• Pulse Oximetry Instruments
• Newborn Disorder Screening Instruments
• Hearing Screening Instruments
o Hearing Screening Accessories
o Hearing Screening Devices

Technologies Covered:
• Hearing Screen
• Enzyme Based Assays
• Tandem Mass Spectrometry
• Pulse Oximetry
• Electrophoresis
• DNA-based Assays
• Immunoassays

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain  
o Rest of Europe    
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific    
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancement

1 Executive Summary    
      
2 Preface 
    
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats    
 3.6 Product Analysis   
 3.7 Technology Analysis  
 3.8 Emerging Markets   
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Newborn Screening Market, By Test Type 
 5.1 Introduction   
 5.2 Critical Congenital Heart Disease (CCHD) 
 5.3 Dry Blood Spot Test   
 5.4 Hearing Screen   
      
6 Global Newborn Screening Market, By Product 
 6.1 Introduction   
 6.2 Reagents and Assay Kits  
 6.3 Pulse Oximetry Instruments  
 6.4 Newborn Disorder Screening Instruments
 6.5 Hearing Screening Instruments 
  6.5.1 Hearing Screening Accessories 
  6.5.2 Hearing Screening Devices 
      
7 Global Newborn Screening Market, By Technology 
 7.1 Introduction   
 7.2 Hearing Screen   
 7.3 Enzyme Based Assays  
 7.4 Tandem Mass Spectrometry  
 7.5 Pulse Oximetry   
 7.6 Electrophoresis   
 7.7 DNA-based Assays   
 7.8 Immunoassays   
      
8 Global Newborn Screening Market, By Geography 
 8.1 North America   
  8.1.1 US   
  8.1.2 Canada   
  8.1.3 Mexico   
 8.2 Europe    
  8.2.1 Germany   
  8.2.2 France   
  8.2.3 Italy   
  8.2.4 UK   
  8.2.5 Spain   
  8.2.6 Rest of Europe  
 8.3 Asia Pacific   
  8.3.1 Japan   
  8.3.2 China   
  8.3.3 India   
  8.3.4 Australia   
  8.3.5 New Zealand  
  8.3.6 Rest of Asia Pacific  
 8.4 Rest of the World   
  8.4.1 Middle East  
  8.4.2 Brazil   
  8.4.3 Argentina  
  8.4.4 South Africa  
  8.4.5 Egypt   
      
9 Key Developments    
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers  
 9.3 New Product Launch  
 9.4 Expansions   
 9.5 Other Key Strategies  
      
10 Company Profiling    
 10.1 GE Healthcare   
 10.2 Covidien, Plc.   
 10.3 Agilent Technologies Inc.   
 10.4 Masimo Corp.   
 10.5 Perkinelmer, Inc.   
 10.6 AB Sciex LLC   
 10.7 Natus Medical Incorporated   
 10.8 Waters Corporation   
 10.9 Trivitron Healthcare   
 10.10 Bio-Rad Laboratories, Inc.   
 10.11 Quest Diagnostics Inc  
 10.12 Illumina, Inc.   
 10.13 Laboratory Corporation Of America Holdings


List of Tables     
1 Global Newborn Screening Market Outlook, By Region (2013-2022) ($MN)
2 Global Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
3 Global Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
4 Global Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
5 Global Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
6 Global Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
7 Global Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
8 Global Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
9 Global Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
10 Global Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
11 Global Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
12 Global Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
13 Global Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
14 Global Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
15 Global Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
16 Global Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
17 Global Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
18 Global Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
19 Global Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
20 Global Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)
21 North America Newborn Screening Market Outlook, By Country (2013-2022) ($MN)
22 North America Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
23 North America Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
24 North America Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
25 North America Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
26 North America Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
27 North America Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
28 North America Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
29 North America Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
30 North America Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
31 North America Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
32 North America Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
33 North America Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
34 North America Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
35 North America Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
36 North America Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
37 North America Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
38 North America Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
39 North America Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
40 North America Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)
41 Europe Newborn Screening Market Outlook, By Country (2013-2022) ($MN)
42 Europe Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
43 Europe Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
44 Europe Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
45 Europe Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
46 Europe Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
47 Europe Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
48 Europe Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
49 Europe Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
50 Europe Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
51 Europe Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
52 Europe Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
53 Europe Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
54 Europe Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
55 Europe Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
56 Europe Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
57 Europe Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
58 Europe Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
59 Europe Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
60 Europe Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)
61 Asia Pacific Newborn Screening Market Outlook, By Country (2013-2022) ($MN)
62 Asia Pacific Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
63 Asia Pacific Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
64 Asia Pacific Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
65 Asia Pacific Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
66 Asia Pacific Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
67 Asia Pacific Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
68 Asia Pacific Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
69 Asia Pacific Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
70 Asia Pacific Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
71 Asia Pacific Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
72 Asia Pacific Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
73 Asia Pacific Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
74 Asia Pacific Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
75 Asia Pacific Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
76 Asia Pacific Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
77 Asia Pacific Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
78 Asia Pacific Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
79 Asia Pacific Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
80 Asia Pacific Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)
81 RoW Newborn Screening Market Outlook, By Country (2013-2022) ($MN)
82 RoW Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
83 RoW Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
84 RoW Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
85 RoW Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
86 RoW Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
87 RoW Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
88 RoW Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
89 RoW Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
90 RoW Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
91 RoW Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
92 RoW Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
93 RoW Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
94 RoW Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
95 RoW Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
96 RoW Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
97 RoW Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
98 RoW Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
99 RoW Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
100 RoW Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials